Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma

NCT00704665 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

231

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis

Interventions

DRUG: Relaxin
DRUG: Relaxin

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]